Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 3172-3175, December 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogawa, M.
Right arrow Articles by McCulloch, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogawa, M.
Right arrow Articles by McCulloch, E. A.

Studies of Nitrogen Mustard Transport by Mouse Myeloma and Hemopoietic Precursor Cells1

Makio Ogawa2, Daniel E. Bergsagel and E. A. McCulloch

Department of Medicine, The Ontario Cancer Institute, and the University of Toronto, Toronto, Ontario, Canada

We studied the transport of nitrogen mustard (HN2) by mouse hemopoietic and transplantable myeloma (Adj. PC-5 and MOPC 460D) stem cells, using gradients of temperature and choline chloride. Bone marrow and myeloma cells were exposed to HN2 in culture at various temperatures, washed, and tested for colony-forming efficiency. The protective effect of lowered temperatures was similar for normal marrow colony-forming units and both lines of myeloma cells. When cells were exposed to HN2 in the presence of choline chloride, the survival of colony-forming units increased, and the dose response curves were similar among the three classes of cells. We were unable to demonstrate a qualitative difference in the transport of HN2 by mouse hemopoietic precursor cells and the stem cells of two myelomas with different sensitivities to HN2.

1 This investigation was supported by a grant from The Ontario Cancer Treatment and Research Foundation.

2 Research Fellow of The Ontario Cancer Treatment and Research Foundation.

Received 6/ 8/73. Accepted 9/ 5/73.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.